10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Worsening chronic heart failure (HF) is a major public health problem.

          Related collections

          Author and article information

          Journal
          JAMA
          JAMA
          1538-3598
          0098-7484
          Dec 1 2015
          : 314
          : 21
          Affiliations
          [1 ] Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
          [2 ] Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
          [3 ] Division of Cardiology, Stony Brook University, Stony Brook, New York.
          [4 ] Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
          [5 ] Department of Cardiology, National Heart Centre Singapore and Duke, National University of Singapore, Singapore.
          [6 ] Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy.
          [7 ] Department of Heart Diseases, Medical University, Military Hospital, Wroclaw, Poland.
          [8 ] Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
          [9 ] Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
          [10 ] Department of Internal Medicine and Cardiology, Charité University Medicine Berlin-Campus Virchow Klinikum, Berlin, Germany.
          [11 ] Bayer, São Paulo, Brazil.
          [12 ] Bayer Pharma, Wuppertal, Germany.
          [13 ] Department of Internal Medicine and Cardiology, Charité University Medicine Berlin-Campus Virchow Klinikum, Berlin, Germany13Department of Internal Medicine and Cardiology, German Heart Center Berlin, Berlin, Germany.
          Article
          2469195
          10.1001/jama.2015.15734
          26547357
          edf07609-6019-4688-a756-5d405c9c3969
          History

          Comments

          Comment on this article